ArticleActa pharmaceutica Sinica. B2026
Elesclomol-mediated cuproptosis overcomes cisplatin resistance by restricting epigenetically activated mitochondrial respiration: Novel therapeutic insights into cisplatin-elesclomol combination therapy.
Tianyu Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.